New
VRF will discontinue collaboration with JPD and OMICS Group.
Vitiligo Research Foundation Board has decided to discontinue it's collaboration with the Journal of Pigmentary Disorders and OMICS Group, effective September 27, 2015. We wish OMICS Group all the best in their future business endeavors that would no longer include use of logo, names or references to VR Foundation, it's Board Members or Executives.
FAQOther Questions
- How can I cure vitiligo?
Right now, there is no universal "cure," but we have entered a new era of treatment. Today, managing vitiligo isn’t just about "hiding" it; it’s about sophisticated science that...
- Vitiligo and hearing loss: any connection?
Vitiligo is primarily recognized for causing skin discoloration, but it can also impact melanocytes in unexpected areas, such as the inner ear. This raises questions about wheth...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.